Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04683354
Title Phase I Study of HL-085 in Patients With Advanced Solid Tumor Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kechow Pharma, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
CCARE San Marcos California 92069 United States Details
Comprehensive Cancer Centers Las Vegas Nevada 89169 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
SCRI Nashville Tennessee 37203 United States Details
Oncology Consultants Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field